Arbutus Biopharma Corp
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $71.0M | $236.9M | $81.3M |
| Jun 2022 | $62.7M | $215.8M | $47.3M |
| Sep 2022 | $58.3M | $203.8M | $24.0M |
| Dec 2022 | $58.6M | $195.4M | $30.8M |
| Mar 2023 | $47.3M | $191.2M | $40.6M |
| Jun 2023 | $42.1M | $176.8M | $27.2M |
| Sep 2023 | $39.3M | $158.6M | $17.5M |
| Dec 2023 | $38.4M | $144.4M | $26.3M |
| Mar 2024 | $35.7M | $150.3M | $43.1M |
| Jun 2024 | $37.6M | $160.0M | $62.8M |
| Sep 2024 | $33.6M | $140.4M | $31.8M |
| Dec 2024 | $34.3M | $131.7M | $36.3M |
| Mar 2025 | $37.9M | $117.0M | $37.1M |
| Jun 2025 | $20.3M | $103.3M | $37.4M |
| Sep 2025 | $20.3M | $97.7M | $22.4M |
| Dec 2025 | $18.0M | $94.6M | $18.0M |
| Mar 2026 | $17.0M | $277.2M | $23.7M |
| Jun 2026 | $15.3M | $274.0M | $19.2M |